CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Janssen Products LP v. Cipla Ltd.

1:15-cv-00307

Overview

Case Number 1:15-cv-00307
Filing Date 2015-04-10
Status Litigation filed
Court ded
Nature of Suit 830 Patent

Parties

Defendant

Cipla USA Inc.

Represented By

0 Attorneys Listed
No attorneys available

Cipla Ltd.

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Janssen Sciences Ireland UC

Represented By

3 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Janssen Products LP

Represented By

3 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Court & Judges

Court

ded

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Docket Entries

COMPLAINT filed against Cipla Ltd., Cipla USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1706071.) - filed by Janssen Products LP, Janssen Sciences Ireland UC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(aah) (Entered: 04/13/2015)

2015-04-10
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 04/13/2015)

2015-04-10
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 2, 2015. Date of Expiration of Patent: December 26, 2026.Thirty Month Stay Deadline: 9/2/2017. (aah) (Entered: 04/13/2015)

2015-04-10
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 2, 2015. Date of Expiration of Patent: February 16, 2024.Thirty Month Stay Deadline: 9/2/2017. (aah) (Entered: 04/13/2015)

2015-04-10
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc